| 5YC0: reference: Exceptional Potency and Structural Basis of a T1249-Derived Lipopeptide Fusion Inhibitor against HIV-1, HIV-2, and Simian Immunodeficiency Virus., Zhu Y, Zhang X, Ding X, Chong H, Cui S, He J, Wang X, He Y, J Biol Chem. 2018 Feb 7. pii: RA118.001729. doi: 10.1074/jbc.RA118.001729. PMID: 29425101 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).